BioSpace News Archive

According to the report, the global smart hospitals market was valued at US$ 22.43 Bn in 2019. The market is projected to expand at a higher CAGR from 2020 to 2030.

Transparency Market Research has published a new report titled, ‘Global Remote Patient Monitoring Devices Market’.

Transparency Market Research has published a new report titled, ‘Electronic Health Records Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Transparency Market Research has published a new report titled, ‘Diabetes Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The global cleanroom consumables market was valued over US$ 16.4 Bn in 2020 and is projected to expand at a CAGR of 0.4% from 2021 to 2031.

Science Applications International Corp. (NYSE: SAIC ) today announced the appointment of two new senior vice presidents of Human Resources (HR) and a new corporate controller.

NLS Pharmaceutics Ltd. announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the First Annual Access to Giving Virtual Investor Conference on July 13-15, 2021.

Bacainn Therapeutics, Inc. today presented results at the European Crohn’s and Colitis Organisation’s 2021 Virtual Congress from a Phase 1 study that showed its lead asset BT051 was safe and well-tolerated in healthy adults. BT051 is an oral, locally-acting inhibitor of neutrophil trafficking and activation and is in clinical development for the treatment of inflammatory bowel disease (IBD), which impacts as many as 6.8 million people in the United States and Europe

RhoVac AB (“RhoVac”), a Swedish cancer immunotherapy company, announces today on July 9th 2021, that its Safety Monitoring Committee has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as BRaVac.

St. Jude Children’s Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir.